Matrixx Initiatives, Inc., et al. v. James Siracusano and NECA-IBEW Pension Fund

Published on:
August 27, 2010

SIFMA has submitted an Amicus “Friend of the Court” Brief

Court:

U.S. Supreme Court

Amicus Issue:

Whether a plaintiff can state a claim under § 10(b) of the Securities Exchange Act and SEC Rule 10b-5 based on a pharmaceutical company’s nondisclosure of adverse event reports even though the reports are not alleged to be statistically significant.

Counsel of Record:

Dewey & LeBoeuf LLP

1101 New York Avenue, NW

Washington, DC 20005

Lyle Roberts

Jonathan E. Richman

N. Noelle Francis

Other Amici on SIFMA’s Brief:

U.S. Chamber of Commerce

Details

Download

More Content

  • Amicus Briefs
    Oct 05, 2026

    In re The Boeing Company Securities Litigation

  • Letters
    Oct 05, 2026

    Reducing Duplicative Regulation and Expanding Exemptions for Commodity Pool Operators and Commodity Trading Advisors

    SIFMA AMG comments on CFTC proposals to reduce duplicative regulation for certain CPOs and CTAs and account for inflation.
  • Letters
    Sep 30, 2026

    Proposed Rule Change to Amend FINRA Rules 0150, 2165, 4512 and to Adopt FINRA Rule 2166

    SIFMA Comments to SEC in support of the proposed rule changes to improve the utilization of Rules 2165 and 4512, as well as the new Rule 2166 to allow for a temporary delay for suspected fraud.

Get the latest trends, stats, and research on financial markets and securities.